PROTAC sEH degrader-2
PROTAC sEH degrader-2 is a soluble epoxide hydrolase (sEH) PROTAC degrader, with pIC50 values of 8.37 and 7.12 against hsEH-H and msEH-H, respectively. PROTAC sEH degrader-2 induces targeted degradation of sEH via the ubiquitin-proteasome system, thereby completely blocking its dual functions as an epoxide hydrolase and a lipid phosphatase by bridging the short-branch exit of sEH with the CRBN E3 ubiquitin ligase. PROTAC sEH degrader-2 can be used in the research of neuroinflammation and Alzheimer's disease.
(Pink: sEH ligand (HY-174225); Blue: Cereblon ligand (HY-103597); Black: linker).
For research use only. We do not sell to patients.
- Formula: C54H57F4N9O13S
- Molecular Weight:1148.14
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
hsEH-H 8.37 (pIC50) |
msEH-H 7.12 (pIC50) |
In Vitro
PROTAC sEH degrader-2 (Compound 23) (3 nM-3 μM; 1-24 h) induces dose- and time-dependent degradation of sEH in HeLasEH-HiBiT cells[1].
PROTAC sEH degrader-2 (3 μM; 3 h) significantly reduces the conversion of 14 (15)-, 11 (12)-, and 8 (9)-EpETrE into their corresponding DiHETrE metabolites in HeLasEH-HiBiT cell homogenates[1].
PROTAC sEH degrader-2 (300 nM; 18 h) significantly reduces sEH expression levels in LPS (HY-D1056)- and IFNγ-activated human M1 macrophages, primary mouse hepatocytes, and precision-cut lung slices (PCLS)[1].
PROTAC sEH degrader-2 (up to 50 μM; 72 h) does not induce significant cytotoxicity in HepG2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human M1 macrophages (activated by LPS and IFNγ)
-
Concentration:300 nM
-
Incubation Time:18 h
-
Result:Successfully triggered sEH degradation in primary human M1 macrophages.
Significantly downregulating sEH expression levels (approx. 10% residual expression) compared to the untreated group, while the inactive control 31 was ineffective.
-
Cell Line:Primary murine hepatocytes
-
Concentration:300 nM
-
Incubation Time:18 h
-
Result:Elicited significant degradation of sEH protein in primary murine hepatocytes (approx. 60% residual expression), though the degradation efficiency was lower than that observed in human macrophages.
Chemical Information
-
Molecular Weight 1148.14
-
Formula C54H57F4N9O13S
-
SMILES
O=C(NCC1=C(C=C(C=C1)NS(=O)(CCCC2=CN(N=N2)CCOCCOCCOCCOCCNC(COC3=C(C(N(C4C(NC(CC4)=O)=O)C5=O)=O)C5=CC=C3)=O)=O)C(F)(F)F)C6=CC=C7N(C=CC7=C6)CC8=CC=CC(F)=C8
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- PROTAC sEH degrader-2
- PROTAC sEH degrader2
- PROTAC sEH degrader 2
- PROTACs
- Epoxide Hydrolase
- primary mouse hepatocytes
- soluble epoxide hydrolase
- ubiquitinylation
- HepG2 cells
- precision-cut lung slices
- HeLasEH-HiBiT cells
- rat liver microsomes
- human M1 macrophages
- cereblon
- mouse liver microsomes
- Inhibitor
- inhibitor
- inhibit